Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/16/24 04:05:00 on US and Canada Markets.
Utz Brands, Inc. (NYSE: UTZ) (“Utz” or the “Company”), a leading U.S. manufacturer of branded salty snacks, today announced it plans to report its first quarter 2024 financial results on Thursday, May 2, 2024, before market open. The Company will host a conference ...
Datadog Announces Date of First Quarter Fiscal Year 2024 Earnings Call PR Newswire NEW YORK , April 16, 2024 /PRNewswire/ -- Datadog, Inc. (NASDAQ:DDOG), the monitoring and security platform for cloud applications, today announced that it will report its first qu...
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS ) today provided the following preliminary update on its investment portfo...
Omnicom Reports First Quarter 2024 Results PR Newswire Revenue of $3.6 billion , with organic growth of 4.0% Diluted earnings per share of $1.59 ; $1.67 Non-GAAP adjusted Operating income of $478.9 million and 13.2% margin EBITA of $50...
Gen to Announce Fiscal 2024 Fourth Quarter and Full-Year Results on May 9, 2024 PR Newswire TEMPE, Ariz. and PRAGUE , April 16, 2024 /PRNewswire/ -- Gen Digital Inc. (NASDAQ: GEN) today announced that its fiscal 2024 fourth quarter and full-year financia...
GAAP DILUTED EPS OF $1.61, ADJUSTED 1 EPS OF $1.64 GAAP NET REVENUES OF $1,203 MILLION, ADJUSTED NET REVENUES OF $1,216 MILLION RAISES QUARTERLY DIVIDEND FROM $0.10 TO $0.25 Interactive Brokers Group, Inc. (Nasdaq: IBKR), an automated global electronic broker, announ...
Over 40 solid tumor patients have completed all biomarker testing in the screening protocol; ~60% of these patients qualify for at least one TCR-T in the ImmunoBank and ~30% are eligible for multiplex therapy Patients identified across all six TCR-T cohorts in solid tumor program with d...
Long term extension of the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 demonstrated significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p<0.05) Significantly improved clinical outcomes associated with long-term daily or...
HAMILTON, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 23, 2024 at 8:30 a.m. Eastern Time to report its first quarter 2024 financial results and recent portfolio ...
CarParts.com Sets First Quarter 2024 Conference Call for Tuesday, May 7, 2024 PR Newswire TORRANCE, Calif. , April 16, 2024 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ: PRTS) will hold a conference call on Tuesday, May 7, 2024 at 2:00 p.m. Pacific Time ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
52.25%Change Percent:
ASLAN Pharmaceuticals Limited Company Name:
ASLN Stock Symbol:
NASDAQ Market:
aslanpharma.com Website: